MX2007002814A - Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion. - Google Patents

Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion.

Info

Publication number
MX2007002814A
MX2007002814A MX2007002814A MX2007002814A MX2007002814A MX 2007002814 A MX2007002814 A MX 2007002814A MX 2007002814 A MX2007002814 A MX 2007002814A MX 2007002814 A MX2007002814 A MX 2007002814A MX 2007002814 A MX2007002814 A MX 2007002814A
Authority
MX
Mexico
Prior art keywords
propylene glycol
penetration enhancer
testosterone gels
testosterone
gels
Prior art date
Application number
MX2007002814A
Other languages
English (en)
Spanish (es)
Inventor
Dominique Salin-Drouin
Original Assignee
Besins Int Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04292170A external-priority patent/EP1634583A1/en
Application filed by Besins Int Lab filed Critical Besins Int Lab
Publication of MX2007002814A publication Critical patent/MX2007002814A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
MX2007002814A 2004-09-09 2005-09-07 Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion. MX2007002814A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04292170A EP1634583A1 (en) 2004-09-09 2004-09-09 Testosterone gels comprising propylene glycol as penetration enhancer
US63836004P 2004-12-23 2004-12-23
PCT/EP2005/010293 WO2006027278A1 (en) 2004-09-09 2005-09-07 Testosterone gels comprising propylene glycol as penetration enhancer

Publications (1)

Publication Number Publication Date
MX2007002814A true MX2007002814A (es) 2007-05-16

Family

ID=39381985

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002814A MX2007002814A (es) 2004-09-09 2005-09-07 Geles de testosterona comprendiendo propilenglicol como mejorador de penetracion.

Country Status (6)

Country Link
JP (1) JP2008512425A (enExample)
BR (1) BRPI0515040B1 (enExample)
EA (1) EA013430B1 (enExample)
IL (1) IL181583A0 (enExample)
MX (1) MX2007002814A (enExample)
NZ (1) NZ553446A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
CN107949389A (zh) * 2015-09-30 2018-04-20 富士胶片株式会社 经皮吸收用组合物
JP7220473B2 (ja) * 2017-10-30 2023-02-10 帝國製薬株式会社 経皮投与製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107517T1 (de) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd Transdermales therapeutisches mittel.
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
HRP20030510A2 (en) * 2000-12-22 2005-04-30 Dr. August Wolff Gmbh & Co. Arzneimittel Gel composition and trans-scrotal application of acomposition for the treatment of hypogonadism
EP1317921B1 (fr) * 2001-12-07 2009-08-19 Besins International Belgique Composition pharmaceutique sous forme de gel ou de solution à base de dihydrotestostérone, son procédé de préparation et ses utilisations
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition

Also Published As

Publication number Publication date
HK1099887A1 (en) 2007-08-24
JP2008512425A (ja) 2008-04-24
EA200700580A1 (ru) 2007-08-31
IL181583A0 (en) 2007-07-04
EA013430B1 (ru) 2010-04-30
BRPI0515040A (pt) 2008-07-01
BRPI0515040B1 (pt) 2021-10-13
NZ553446A (en) 2010-05-28

Similar Documents

Publication Publication Date Title
WO2006138418A3 (en) Improvement of cognitive performance with sirtuin activators
SG152292A1 (en) Pharmaceutical compositions
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
NO20071823L (no) Testosterongeler omfattende polypropylenglykol som gjennomtrengningsforsterker
GB0119011D0 (en) Treatment of nail infections
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
TW200732349A (en) Anti-OX40L antibodies and methods using same
DE602005014628D1 (de) Embolie-teilchen
MX2013004123A (es) Composiciones antitusigenas que comprenden memantina.
EP1893196A4 (en) DIARYLHYDANTOIN CONNECTIONS
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
IL190730A0 (en) Potassium channel inhibitors
MY160565A (en) Chalcones as enhancer of antimicrobial agents
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
EP2129672A4 (en) ESTER AND CARBAMATE AZAADAMANTANE DERIVATIVES AND METHODS OF USE
EA200801049A1 (ru) Усовершенствованный тестостероновый гель и способ его применения
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
EP1637167A3 (en) New injectable formulations containing progesterone
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
MXPA05008902A (es) Soluciones de drogas en mentol.
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
SG165404A1 (en) Fulvestrant formulation
ZA200604874B (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights